A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)
Kevin C. Maki, David G. Orloff(Medpace (United States)), Stephen J. Nicholls(South Australian Health and Medical Research Institute), Richard L. Dunbar(University of Pennsylvania), Eli M. Roth(Sterling Research Group), Danielle Curcio(Idera Pharmaceuticals (United States)), Judith Johnson(Idera Pharmaceuticals (United States)), Douglas Kling(Idera Pharmaceuticals (United States)), Michael H. Davidson(Idera Pharmaceuticals (United States))
Cited by 105
Abstract
Related Papers
No related papers found
Powered by citation graph analysis